Calithera Biosciences Stock News

SOUTH SAN FRANCISCO, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company, today announced that Susan Molineaux, Ph.D., the companys founder, president and chief executive officer, will present at the H.C. Wainwright BioConnect Virtual Conference.

SOUTH SAN FRANCISCO, Calif., Jan. 05, 2022 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company, today announced that Susan Mo

Equities research analysts expect that Calithera Biosciences, Inc. (NASDAQ:CALA) will report earnings per share of ($0.20) for the current quarter, according to Zacks Investment Research. Zero analysts have made estimates for Calithera Biosciences earnings, with the lowest EPS estimate coming in at ($0.28) and the highest estimate coming in at ($0.11). Calithera Biosciences reported earnings []

Equities research analysts forecast that Calithera Biosciences, Inc. (NASDAQ:CALA) will post ($0.20) earnings per share for the current quarter, Zacks reports. Zero analysts have provided estimates for Calithera Biosciences earnings. The highest EPS estimate is ($0.11) and the lowest is ($0.28). Calithera Biosciences reported earnings per share of ($0.32) in the same quarter last year, []

Calithera Biosciences, Inc. (NASDAQ:CALA) with the stream of -4.23% also noticed, India The Southern Company (NYSE:SO) encountered a rapid change of -0.32% in the last hour of Tuesdays trading session. The post Stock Runner: Calithera Biosciences, Inc. (NASDAQ:CALA), The Southern Company (NYSE:SO) appeared first on Stocks Equity .

Powerbridge Technologies Co., Ltd. (PBTS) with the stream of -18.17% also noticed, India Calithera Biosciences, Inc. (CALA) encountered a rapid change of -10.25% in the last hour of Fridays trading The post Have an attention on: Powerbridge Technologies Co., Ltd. (NASDAQ:PBTS), Calithera Biosciences, Inc. (NASDAQ:CALA) appeared first on Stocks Equity .

Investors need to pay close attention to Calithera Biosciences (CALA) stock based on the movements in the options market lately.

Investors need to pay close attention to Calithera Biosciences (CALA) stock based on the movements in the options market lately.

Calithera Biosciences, Inc. (CALA) with the stream of -3.56% also noticed, India Senmiao Technology Limited (AIHS) encountered a rapid change of -2.72% in the last hour of Fridays trading session. The post Up to Date Trending Stock: Calithera Biosciences, Inc. (NASDAQ:CALA), Senmiao Technology Limited (NASDAQ:AIHS) appeared first on Stocks Equity .

Equities research analysts expect that Calithera Biosciences, Inc. (NASDAQ:CALA) will announce earnings of ($0.20) per share for the current fiscal quarter, according to Zacks Investment Research. Zero analysts have issued estimates for Calithera Biosciences earnings, with the lowest EPS estimate coming in at ($0.28) and the highest estimate coming in at ($0.11). Calithera Biosciences posted []

The stock price of Calithera Biosciences Inc (NASDAQ: CALA) increased by over 20% pre-market today. This is why it happened.

Calithera Biosciences, Inc. (CALA) with the stream of -4.94% also noticed, India NIKE, Inc. (NKE) encountered a rapid change of 1.39% in the last hour of Tuesdays trading session. Calithera The post Oscillating Stock: Calithera Biosciences, Inc. (NASDAQ:CALA), NIKE, Inc. (NYSE:NKE) appeared first on Stocks Equity .

SOUTH SAN FRANCISCO, Calif., Nov. 12, 2021 (GLOBE NEWSWIRE) -- Calithera Biosciences, Inc. (Nasdaq: CALA), a clinical-stage, precision oncology biopharmaceutical company, today announced that Susan Mo

Calithera Biosciences, Inc. (CALA) CEO Susan Molineaux on Q3 2021 Results - Earnings Call Transcript

Calithera Biosciences Inc (NASDAQ: CALA) has decided to terminate its phase 2 KEAPSAKE trial based on a lack of clinical benefit observed in patients treated with telaglenastat in an interim analys